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Aim: Sex-based differences in response to adverse prenatal environments and infant 
outcomes have been observed, yet the underlying mechanisms for this are unclear. 
The placental epigenome may be a driver of these differences. Methods: Placental 
DNA methylation was assessed at more than 480,000 CpG sites from male and female 
infants enrolled in the extremely low gestational age newborns cohort (ELGAN) and 
validated in a separate US-based cohort. The impact of gestational age on placental 
DNA methylation was further examined using the New Hampshire Birth Cohort Study 
for a total of n = 467 placentas. Results: A total of n = 2745 CpG sites, representing n 
= 587 genes, were identified as differentially methylated (p < 1 × 10-7). The majority (n 
= 582 or 99%) of these were conserved among the New Hampshire Birth Cohort. The 
identified genes encode proteins related to immune function, growth/transcription 
factor signaling and transport across cell membranes. Conclusion: These data 
highlight sex-dependent epigenetic patterning in the placenta and provide insight 
into differences in infant outcomes and responses to the perinatal environment.
First draft submitted: 30 September 2016; Accepted for publication: 10 January 2017; 
Published online: 17 February 2017
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The placenta serves as the primary organ 
responsible for regulation of the prenatal 
environment critical for optimal fetal devel-
opment. It is a nutrient transporter and 
produces vital hormones to maintain preg-
nancy and support the fetus [1]. In contrast 
to these essential functions, the placenta also 
serves as a source of exposure for toxic sub-
stances, dysregulated hormone signaling and 
immune-related proteins [2]. Such exposures 
including maternal stress, excess hormones, 
cytokines or environmental toxicants impact 
fetal health and influence later-life health 
outcomes [3–11].
An increasing body of literature supports 
sex-specific birth and later-life outcomes in 
relation to adverse in utero environments [12]. 
For example, sex-specific perinatal and later-
life outcomes have been linked to toxic sub-
stance exposure [5,6,13–16], maternal stress [7] 
and maternal immune status [9,17,18]. We 
hypothesize that sex-dependent health out-
comes in infants may be associated with 
sexual dimorphism of the placenta. In sup-
port of this hypothesis, physiologic differ-
ences between male and female placentas 
have been observed [19]. For example, pla-
centas derived from pregnancies of males 
and females display variation in the abun-
dance and type of glucocorticoid transporter 
proteins, the expression of hormones and 
the production of immune-related proteins 
including cytokines [12,19–21]. In addition, 
sex-based differences in response to prenatal 
stressors have been observed at the levels of 
the placental proteome, transcriptome and 
epigenome [3,7,14,20,22–27]. Thus, the sexu-
ally dimorphic nature of the placenta could 
influence variation in toxicant transport and 
accumulation, hormone levels and immune 
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response experienced by the fetus. While key physi-
ological differences have been observed in male and 
female placentas, the underlying mechanisms are not 
well established.
Epigenetic regulation may underlie the physiologic 
differences observed between male and female pla-
centas [12]. For instance, key differences in chromatin 
structure have been observed between male and female 
placentas, suggesting that there is a role for epigen-
etic regulation in placental sexual dimorphism [12,21]. 
Understanding epigenetic regulation in the placenta 
is important given the modifiability of its epigenome 
in response to prenatal stressors, and its role as a 
mediator of the developmental origins of health and 
disease [2,20,21,28]. Additionally, because certain epig-
enomic markers are stable over time [29], it is possible 
that changes to the fetal placenta methylome explain 
the sex-based differences in later-life disease risks.
To our knowledge, this study is among the first to 
address the gap in knowledge related to sexual dimor-
phism of the placental DNA methylome. Here, we 
investigated whether DNA (CpG) methylation pat-
terns in the placenta differed based on the sex of the 
fetus. Sex-based differences within the placenta were 
identified in a subset of subjects from the extremely low 
gestational age newborns (ELGAN) cohort [30–35], and 
validated in a replication cohort comprised of women 
recruited at the University of North Carolina (UNC) 
hospitals [36]. To confirm that gestational age was not 
a major driver of the differences in DNA methylation, 
all data were subsequently compared with CpG meth-
ylation assessed in the New Hampshire Birth Cohort. 
The goal of these analyses is to provide key insights 
into whether sexual dimorphism of the placental meth-
ylome may explain differential susceptibility to adverse 
prenatal environmental conditions.
Methods
ELGAN study subject recruitment & sample 
collection
ELGAN study recruitment has been previously 
described in detail [37]. In short, from 2002 to 2004, 
women giving birth at one of the 14 participating sites 
before 28 weeks gestation were asked to enroll in the 
ELGAN study. Their consent was provided either upon 
hospital admission prior to or shortly after delivery. All 
procedures were approved by the Institutional Review 
Board at each of the 14 participating study sites.
A total of 1506 infants and 1249 mothers enrolled 
in the ELGAN study. A subcohort of 84 mother-infant 
pairs, representative of the larger cohort, were selected 
for this analysis. As part of participation in ELGAN, 
women were asked to contribute their placentas. A 
description of the methodology that was used for pla-
cental collection is as follows: delivered placentas were 
placed in a sterile exam basin and transported to a 
sampling room, where they were biopsied under ster-
ile conditions. At the midpoint of the longest distance 
between the cord insertion and the edge of the pla-
cental disk, the amnion was pulled back using sterile 
technique to expose the chorion. Traction was applied 
to the chorion and the underlying trophoblast tissue 
and a piece of tissue was removed by cutting at the 
base of the section. The tissue was placed into a cryo 
vial and immediately immersed in the liquid nitro-
gen. Specimens were stored at -80°C until laboratory 
 processing [38].
The replication cohort included 40 subjects of 
women receiving obstetric care at UNC hospitals who 
consented to collection of placental samples at the time 
of birth. Subjects gave written informed consent prior 
to enrollment and participation in this study. A full-
thickness placental biopsy was obtained after delivery, 
avoiding the periphery and areas of obvious infarction. 
Samples were flash frozen in liquid nitrogen, and stored 
at -70°C until analysis. This research was approved by 
the Institutional Review Board at the University of 
North Carolina (#11–2054).
Data from a third cohort comprising 343 placenta 
samples obtained from women and children involved 
in the New Hampshire Birth Cohort, an ongoing pro-
spective pregnancy and birth cohort, were utilized as a 
contrast and validation of the results in a cohort with 
a more generalizable spread of gestational age. This 
cohort and the placental DNA methylation array data 
have been previously described [39]. Briefly, pregnant 
women whose primary source of residential water is a 
private well and who obtained their prenatal care at 
clinics in New Hampshire, were recruited into the 
study. Eligibility criteria were that women were cur-
rently pregnant; 18–45 years old; received routine pre-
natal care at one of the study clinics; used a private well 
that serves <15 households or 25 individuals at their 
residence; resided in the sample place since their last 
menstrual period; and did not plan to move prior to 
delivery. Like the replication cohort, a full-thickness 
placental biopsy was obtained after delivery, avoid-
ing the periphery and areas of obvious infarction, and 
placed immediately in RNA later for at least 48 h, then 
removed from the fixative and stored at -80°C until 
laboratory processing.
DNA extraction & assessment of DNA 
methylation
DNA extraction and assessment of DNA methylation 
was performed as follows. A 0.2 g subsection of placen-
tal tissue was cut from each frozen biopsy on dry ice, 
washed briefly in sterile 1× phosphate-buffered saline 
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(PBS) to remove any residual blood, and homogenized 
in Buffer RLT™ with β-mercaptoethanol (Qiagen, 
CA, USA). DNA and RNA sequences >18 nucleotides 
in length were collected using the AllPrep DNA/RNA/
miRNA Universal Kit (Qiagen, CA, USA), accord-
ing to manufacturer’s instructions. CpG methyla-
tion was assessed using the Illumina HumanMethyl-
ation450 BeadChip© array (Illumina, Inc., CA, USA). 
This platform assesses the DNA methylation levels of 
486,428 individual probes at single nucleotide resolu-
tion. Isolated DNA was first bisulfite converted using 
the EZ DNA methylation kit (Zymo Research, CA, 
USA) and converted DNA was then hybridized onto 
the array. The DNA methylation data were collected at 
Expression Analysis, Inc. (NC, USA; www.expression-
analysis.com). Methylation levels were calculated and 
expressed as β values (β = intensity of the methylated 
allele [M]/intensity of the unmethylated allele [U] + 
intensity of the methylated allele [M] + 100).
Statistical analysis
The array signal data were processed using R software 
(version 3.0.3). For each set of samples, batch effect 
was evaluated using principle component analysis 
and was determined to not be a significant source of 
variation. Any methylation β-values with a detection 
p-value above 0.01 were considered unreliable and were 
removed from analysis. β-mixture quantile normaliza-
tion was performed using the WateRmelon package 
(version 1.11.0) in R [40]. Following normalization, 
probes containing a single nucleotide polymorphism 
in the assayed CpG dinucleotide, as well as those for 
which two or more single nucleotide polymorphisms 
were located in the probe sequence were removed. Last, 
probes on the Y chromosome were removed from this 
study as they were not comparable between male and 
female placental samples [41,42]. A total of n = 377,673 
probes, representing 20,442 genes, remained for analy-
sis. β-differences were calculated for differentially 
methylated probes by subtracting the median female 
β-value from the median male β-value. To identify 
covariates, a directed acyclic graph approach was used. 
No factors were identified that influenced both the 
sex of the infant and the methylome. For this reason, 
p-values were calculated from t-statistics. Multiple 
testing correction of the p-values was performed using 
the Bonferroni correction (p < 1 × 10-7) as well as a 
q-value correction, using the Partek Genomic Suite 
(MO, USA).
To replicate these findings, CpG methylation data 
were analyzed in a separate cohort based at UNC hos-
pitals using the HumanMethylation450 BeadChip© 
(Illumina, CA, USA). Data were processed and ana-
lyzed according to the protocol described above, how-
ever data for only those CpG locations which were sta-
tistically significant in the ELGAN dataset were tested 
(n = 4371). This increased the Bonferroni corrected 
p-value threshold to 1 × 10-5. In addition to the valida-
tion performed, t-statistics and a multiple  test-corrected 
q-value were calculated for all probes.
Given the known impact of gestational age on the 
placental DNA methylome [43,44], and that the two 
previously described cohorts utilized in this study were 
of lower gestational age, data from the New Hampshire 
birth cohort [39] were also assessed (n = 343 placen-
tas). In addition, we also performed a second analysis 
where linear regression modeling was used to control 
for  gestational age in each of the cohorts.
Transcription factor binding site analysis of 
validated gene sets
To characterize transcription factor binding site pat-
terns, two separate analyses were conducted. First, 
enriched transcription factor binding site motifs 
were identified using Gene Set Enrichment Analysis 
(GSEA) [45]. This analysis relies on a Kolmogorov–
Smirnov like statistic of an enrichment score to cal-
culate p-values. Subsequently, the p-values are false 
discovery rate corrected by calculating a normalized 
enrichment score. Second, identified transcription 
actors were validated with the Genomatix Com-
mon Transcription Factor Binding Site module using 
 methods as previously described [46].
Gene set-based analysis
In addition to transcription factor binding site analy-
sis, we analyzed whether the differentially methylated 
probes in the placenta were enriched for specific bio-
logical functions. Four gene sets were analyzed where 
gene content was established using www.uniprot.org. 
Specifically, four gene sets were tested: transport-
related genes (n = 3704), immune-related genes (n 
= 1622), inflammation-related genes (n = 410) and 
growth/transcription-related genes (n = 2030). A χ2 
test was used to identify enrichment of key functions. 
This test compares the relative abundance of genes 
associated with a key biological function among those 
found to be differentially methylated to the relative 
abundance across the genome. The p-value repre-
sented the probability of identifying a similar number 
of genes from a random sample of the same size from 
the genome. In addition to the comparison to these 
known functional groups, the identified differentially 
methylated sexually dimorphic genes were also com-
pared with 142 genes that have been previously identi-
fied as having sexually dimorphic gene expression in 
human placentas [47]. These data were collected from 
a previous meta-analysis that identified genes differen-
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tially expressed in male and female placentas [47]. For 
these analyses, relaxed statistical significance was used 
to define differentially methylated probes (p < 0.05; q 
< 0.1) [47], to enable comparability to the previously 
published work.
Results
Study subject characteristics
In the ELGAN cohort subset, 58 (69%) were male 
and 26 (31%) were female. In the UNC cohort, 19 
(48%) were male and 21 (53%) were female (Table 1). 
For both cohorts, none of the demographic variables 
differed between males and females. These variables 
included average maternal age, gestational age, parity, 
smoking status and race. Demographic characteristics 
for the New Hampshire Birth Cohort Study have been 
previously published [39].
Identification & replication of differentially 
methylated probes in ELGAN
In the ELGAN cohort, we analyzed CpG meth-
ylation differences between male and female infants 
for 377,673 CpG probes representing 20,442 genes 
across 84 placentas. For this analysis, statistical sig-
nificance was set at the Bonferroni-corrected p-value 
threshold of p < 1 × 10-7. A total of 4371 probes, 
representing 714 genes were found to be differen-
tially methylated between male and female placentas 
(Figure 1, Supplementary Table 1). The vast majority 
(97.9%) of these probes (n = 4280, 666 genes) were 
located on the X chromosome (Table 2). Only 91 dif-
ferentially methylated probes (2.1%), representing 48 
genes, were located in autosomal regions (Table 2). 
When comparing probes that were differentially meth-
ylated between males and females, the greatest absolute 
β-difference displayed was 44.3% and the smallest was 
2.5% (Supplementary Table 1). The majority of probes 
(99.2%) were greater than 5%, a level that has been 
previously used as a threshold while identifying sex-
based differences [41]. Interestingly, and in contrast to 
our a priori hypothesis, 52.5% (n = 2296) probes were 
hypermethylated in males as compared with females 
(Table 2). Hypermethylation of probes in males relative 
to females occurred on both autosomal chromosomes 
(n = 73, 82.4%) and the X chromosome (n = 2223, 
51.9%) (Table 2).
To establish whether CpG methylation levels in the 
ELGAN subjects replicated in a separate cohort, we ana-
lyzed placental CpG methylation data from a cohort of 
40 pregnant women from the UNC hospital. A total of 
2745 probes, representing 587 genes, replicated across 
both cohorts as differentially methylated between male 
and female placentas (Figure 2, Supplementary Table 1).
As noted within the ELGAN subcohort, the vast 
majority of probes 99.2% (n = 2724, 574 genes) were 
located on the X chromosome, and only 21 probes (13 
genes) occurred on autosomal chromosomes (Table 2, 
Table 3). Again we observed similar patterns of hyper-
methylation where 51.3% (n = 1407) probes were 
hypermethylated in males as compared with female 
placentas, and this pattern was true for probes on the 
X chromosome (n = 1394, 51.2%) (Table 2). Addi-
tionally, across cohorts changes in the magnitude and 
direction of methylation were highly consistent as rep-
resented by the strong correlation between β-values (r2 
= 0.95; p < 0.0001) (Figure 3).
Table 1. Demographics.
Sex ELGAN UNC
 Overall 
N (%), (range)
Male 
(n = 58) 
N (%), (range)
Female (n = 26) 
N (%), (range)
Overall 
N (%), (range)
Male 
(n = 19) 
N (%), (range)
Female (n = 21) 
N (%), (range)
M 58 (69%)   19 (48%)   
F 26 (31%)   21 (53%)   
Gestational age 25.5 (23–27) 25.3 (23–27) 25.9 (24–27) 35.6 (22–41) 34.4 (22–41) 36.7 (27–41)
Maternal age 28.6 (16–41) 28.3 (16–41) 29.2 (18–39) 28.3 (19–38) 28.8 (20–35) 27.7 (19–38)
Race       
White 38 (45%) 24 (41%) 14 (39%) 13 (33%) 6 (32%) 5 (24%)
Nonwhite 46 (55%) 34 (49%) 12 (61%) 27 (67%) 13 (68%) 16 (76%)
Smoking status       
Yes 12 (14%) 7 (13%) 5 (19%) 3 (8%) 1 (5%) 2 (10%)
No 70 (84%) 49 (84%) 21 (81%) 37 (92%) 18 (95%) 19 (90%)
Not reported 2 (2%) 2 (3%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
ELGAN: Extremely low gestational age newborn; UNC: University of North Carolina.
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Figure 1. Manhattan plot displaying all CpG probes tested for the analysis of sex-dependent DNA methylation 
in the placenta. Probes are organized according to chromosomal positions. Probes in black and gray represent 
probes tested. Probes above the red line were those that were statistically significant. Probes in green are those 
that were validated in the replication cohort.
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Among the replicated sexually dimorphic probes in 
all cohorts (n = 2745 probes, 587 genes), the major-
ity of autosomal probes were located in the gene body 
(38.1%) and were hypermethylated. Interestingly, 
no sexually dimorphic probes were found within the 
TSS200 or 1st Exon (Figure 4). The majority of sexu-
ally dimorphic probes identified in the gene body and 
the 3′UTR were hypermethylated, with the TSS1500 
and unspecified region showing higher proportions of 
hypomethylation (Figure 4). Of the sexually dimor-
phic probes on the X chromosome, the highest pro-
portion were identified in the gene body (21.9%), 
and the majority of these were hypermethylated in 
males relative to females (Figure 4). Additionally, only 
the TSS200, 5′UTR and 1st Exon displayed higher 
 proportions of hypomethylation (Figure 4).
X-inactivation has been previously cited as a poten-
tial mechanism which can account for many of the 
differences for the sexually dimorphic methylation 
changes observed on the X chromosome [26,42]. For this 
reason, the data were compared with genes that escape 
X-inactivation [49] and pseudo-autosomal genes [50]. 
Interestingly, a subset of the genes (n = 10) are known 
to escape X-inactivation (n = 10, 2%), and one XG 
blood group (one, namely XG, was a member of the 
human pseudoautosome (Supplementary Table 2).
Due to concerns about the potential for gestational 
age to impact CpG methylation, these sites were fur-
ther tested in a cohort of 343 women recruited from 
the New Hampshire Birth cohort. In support of 
the primary data, we found replication of n = 2662 
probes and n = 582 genes (99% of validated probes 
Table 2. Comparison of methylation levels among sex-dependent differentially methylated probes.
Differentially methylated probes (DMPs) Overall X Autosomal
 n % n % n % 
DMPs identified in ELGAN 
All probes 4371 - 4280 - 91 -
Hypermethylated probes (βMales > βFemales) 2296 52.5 2223 51.9 73 80.2
Hypomethylated probes (βMales < βFemales) 2075 47.5 2057 48.1 18 19.8
DMPs validated in the replication cohort
All probes 2745 - 2724 - 21 -
Hypermethylated probes (βMales > βFemales) 1407 51.3 1394 51.2 13 61.9
Hypomethylated probes(βMales < βFemales) 1338 48.7 1330 48.8 8 38.1
DMP: Differentially methylated probe; ELGAN: Extremely low gestational age newborn.
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Figure 2. Heatmap displaying the 2745 validated sexually dimorphic probes. Red represents increased methylation 
in males relative to females and blue represents decreased methylation in males relative to females. 
ELGAN: Extremely low gestational age newborn; UNC: University of North Carolina.
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and genes). Importantly, replication occurred for all 
probes across the studies that passed p-value detection. 
Similar results were observed when gestational age was 
included in the model where n = 2561 probes and n = 
568 genes (replication of 92% of probes and genes). 
These data were not considered during downstream 
analyses, but can be found in the Supplementary 
 Materials (Supplementary Tables 1 & 2).
Transcription factor binding site analysis
In addition to characterization of the replicated probes/
genes by region and methylation status, transcription 
factor binding site enrichment analysis was performed 
on the promoter regions of differentially methylated 
genes. An analysis of hypermethylated probes revealed 
an enrichment for binding sites for NFATC (GSEA p 
= 1.07 × 10-26, Genomatix p = 2.23 × 10-4), and PAX4 
(GSEA p = 1.39 × 10-17, Genomatix p = 9.62 × 10-
81). Among hypomethylated probes, binding sites for 
MAZ (GSEA p = 3.68 × 10-27, Genomatix p = 3.56 × 
10-131) and FOXO4/MLLT7 (GSEA p = 4.54 × 10-20, 
Genomatix p = 2.41 ×10-37) were enriched. SP1 was 
significant in both the hypermethylated (GSEA p = 1.6 
× 10-17, Genomatix p = 2.29 × 10-49) and hypomethyl-
ated (GSEA p = 2.29 × 10-30, Genomatix p = 7.82 × 
10-48) gene sets.
Differentially methylated gene sets associated 
with response to the prenatal environment and 
sex-based differential gene expression
In addition to the transcription factor binding site 
analysis, we analyzed whether the differenitally meth-
ylated probes in the placenta were enriched for spe-
cific biological functions, namely transport, immune 
response, inflammation and growth/transcription fac-
tors. For this analysis, probes that were differentially 
methylated (p < 0.05 and q < 0.1) in both cohorts 
were considered (n = 4900 probes, n = 761 genes) 
(Supplementary Table 2). Using a Yates corrected χ2 
test it was determined that immune proteins (n = 31, 
p = 0.0337), transporters (n = 119, p = 0.0233) and 
growth/transcription factors (n = 66, p = 0.0001) were 
enriched (Supplementary Table 2). Only inflammation 
proteins were not enriched (n = 12, p = 0.5623). Signifi-
cantly enriched immune-related genes were involved in 
primary immunodeficiency and Toll-like receptor sig-
naling, such as TLR7 and TLR8. The inflammatory-
response genes included NOD-like receptor signaling 
pathways. Growth/transcription factors related genes 
were associated with neurotrophin and mTOR signal-
ing pathways. Last, transporters tended to be involved 
in neuroactive ligand–receptor interaction and cal-
cium signaling pathways, such as voltage-dependent 
 anion-selective channel protein 1.
Following enrichment analysis, the differentially 
methylated genes identified in the present study were 
compared with a 142 gene set from a meta-analysis 
of sex-dependent differential gene expression within 
the placenta [47]. A total of 23 genes (n = 112 probes) 
that we identified as differentially methylated were 
also differentially expressed in the previous study [47] 
(Supplementary Table 2). This represents 16.2% of 
the 142 differentially expressed genes. Using a Yates 
corrected χ2 test it was determined that the over-
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Table 3. Autosomal sex-dependent differentially methylated probes (n = 21 probes, 13 gene).
Probe ID Gene Position CHR ELGAN Replication
     Median β  Median β 
    p-value Male Female p-value Male Female 
cg26827413   1 1.26 × 10-17 0.873 0.765 3.21 × 10-06 0.808 0.739
cg07170752 DNAH14 Body 1 2.94 × 10-11 0.830 0.782 5.03 × 10-06 0.748 0.678
cg15817705   1 1.84 × 10-10 0.712 0.632 7.89 × 10-06 0.668 0.595
cg11955727   2 3.44 × 10-36 0.593 0.898 1.92 × 10-10 0.532 0.811
cg19484299 MSL3L2 Body 2 2.53 × 10-09 0.877 0.711 1.46 × 10-06 0.761 0.651
cg04462931   7 4.49 × 10-44 0.430 0.879 2.48 × 10-12 0.367 0.783
cg12949927   7 8.67 × 10-34 0.623 0.891 4.61 × 10-09 0.551 0.777
cg20926353 TLE1 5′UTR 9 1.52 × 10-20 0.085 0.327 3.90 × 10-09 0.128 0.306
cg14095100 TLE1 5′UTR 9 3.47 × 10-10 0.053 0.124 5.23 × 10-06 0.098 0.159
cg00167275 FAM35A TSS1500 10 9.37 × 10-14 0.058 0.181 1.82 × 10-07 0.089 0.210
cg04455759 TIMM8B Body 11 1.88 × 10-23 0.922 0.813 3.21 × 10-09 0.845 0.701
cg04981952 PRKRIR 3′UTR 11 7.36 × 10-12 0.668 0.571 4.84 × 10-09 0.626 0.544
cg10402023 SHANK2 Body 11 8.39 × 10-15 0.819 0.945 2.45 × 10-08 0.735 0.856
cg15756407 TIMM8B Body 11 1.82 × 10-25 0.751 0.628 3.23 × 10-06 0.675 0.581
cg24056269 STK24 Body 13 3.83 × 10-28 0.804 0.692 1.49 × 10-07 0.711 0.640
cg24400806   15 2.38 × 10-09 0.842 0.909 6.08 × 10-06 0.746 0.807
cg02015053 EIF3J 3′UTR 15 5.98 × 10-15 0.674 0.571 9.07 × 10-06 0.608 0.543
cg03704667 CHTF8 3′UTR 16 6.56 × 10-19 0.767 0.646 6.01 × 10-06 0.700 0.628
cg02798874 TRPV1 3′UTR 17 2.16 × 10-15 0.655 0.509 3.99 × 10-08 0.603 0.478
cg13192180 NOL11 Body 17 1.20 × 10-18 0.869 0.723 4.41 × 10-07 0.787 0.652
cg11851257 MYST2 Body 17 4.66 × 10-10 0.820 0.733 1.93 × 10-06 0.745 0.669
CHR: Chromosome; ELGAN: Extremely low gestational age newborns. 
lap between studies was statistically significant (p < 
0.0001). This suggests that DNA methylation may 
play a key role in the regulation of gene expression 
linked to sexual dimorphism.
Discussion
Fetal sex is known to influence susceptibility to the 
prenatal environment and can influence differential 
biological signaling within the placenta [3,5–7,12–15,23–
25,27,41]. Therefore, we set out to identify sex-based dif-
ferences in the placental DNA methylomes in three 
independent US-based birth cohorts. We identified a 
total of 587 genes (2745 probes), which were differ-
entially methylated (p < 1 × 10-7) in male placentas as 
compared with female placentas in two cohorts. We 
further validated these probes in a third US cohort of 
normal gestational age and found that 99.2% of probes 
replicated. The majority of these probes were located 
on the X-chromosome, but a subset (n = 21 probes, 13 
genes) were found on autosomal chromosomes. Many 
of the identified genes are involved in the transport and 
transcriptional control of the immune response. Inter-
estingly, some of the genes identified here have been 
previously shown to be sexually dimorphic at the level 
of the placental transcriptome. Overall, our findings 
demonstrate that there is a sexual epigenetic dimor-
phism of the placental DNA methylome.
As previously demonstrated in other studies of fetal 
and adult tissues [22,26,41,42,48,51], the majority of differ-
entially methylated genes were located on the X-chro-
mosome. X-inactivation of one female X chromosome 
has been cited as potential explanation for sex-based 
differential methylation of the X-chromosome [26,42]. 
Interestingly, a subset of the genes identified in this 
study (n = 10) are known to escape X-inactivation [49]. 
One of these differentially methylated genes, XG, 
resides on the human pseudo-autosomal region of the 
X chromosome [50]. Our data highlight the intriguing 
finding that a very slight majority (51%) of the iden-
tified X-chromosome probes were hypermethylated 
in males relative to females. These data contradicted 
our a priori hypothesis that the majority of probes on 
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Figure 3. Comparison of sex-dependent beta 
differences between the extremely low gestational 
age newborns (X-axis) and University of North Carolina 
replication cohort (Y-axis) for all 2745 validated probes. 
Autosomal probes are highlighted in gray, while those 
found on the X-chromosome are represented in black. 
ELGAN: Extremely low gestational age newborn; 
UNC: University of North Carolina.
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the X-chromosome would have higher levels of meth-
ylation in females relative to males. Strong support 
for these data come from their reproducibility across 
three independent cohorts. In addition, other studies 
have identified some sites on the X chromosome that 
display higher levels of methylation in males rela-
tive to females [41,51]. While it may be intuitive that 
X-inactivation would likely present as a pattern of 
hypermethylation in females as compared with male 
placentas, prior research has shown that gene silenc-
ing on the X-chromosome is dependent on gene region 
and in some cases hypomethylation-associated silenc-
ing has been observed [49,52,53]. Taken together, these 
data support that the functional impact of methyla-
tion on X-chromosome inactivation exhibits positional 
dependencies, similar to those observed previously [54].
The sexually dimorphic genes were enriched for 
proteins involved in immune function, micronutrient 
transport and transcription/growth factors [12,20,21]. 
Specifically, immune-related TLR7 was shown to 
be hypermethylated in males relative to females and 
TLR8 was hypomethylated in males as compared with 
females. These immune-related differences between 
the male and female placental methylomes may con-
tribute to differential susceptibility to environmen-
tal exposures between the sexes [8]. For example, an 
enhanced capability for transporting toxicants across 
the placenta in males during the prenatal period may 
be accounted for by differences in activation of the pla-
cental transporter voltage-dependent anion-selective 
channel protein 1, a major calcium transport chan-
nel [55] critical for fetal development. This protein, 
which normally enhances placental micronutrient 
delivery [56], can be hijacked by toxicants to cross cell 
membranes [57] during the prenatal period.
One possible mechanism underlying gene-specific 
genome-wide patterns of DNA methylation is the 
transcription factor occupancy theory [46]. Briefly, this 
theory posits that gene-specific methylation is influ-
enced by transcription factor binding that either pre-
vents or provides access to the DNA sequence for the 
DNA methylation machinery. Supporting this theory, 
we identified that binding sites for several transcrip-
tion factors were significantly enriched in the hyper- 
and hypomethylated genes identified in this analysis. 
For instance, binding sites for NFATC were enriched 
in the promoter regions of the hypomethylated genes. 
Interestingly, in a separate study of placental sexually 
dimorphic gene expression, binding sites for NFATC 
were similarly enriched among the identified genes [47]. 
Additionally, binding sites for MAZ were identified to 
be enriched among the hypomethylated genes. MAZ 
is of interest as it has been previously identified as a 
key transcription factor associated with differential 
methylation patterns observed in response to a diverse 
suite of environmental contaminants [46]. Last, SP1, a 
transcription factor with enriched binding sites among 
both the hyper- and hypomethylated gene sets, is a 
known target of environmental contaminants, specifi-
cally toxic metals [58]. These transcription factors may 
play a role in impacting CpG methylation as well as 
responding to adverse conditions experienced during 
the prenatal environment.
Several factors should be considered in interpreting the 
results of this study. While we identified and validated a 
set of sexually dimorphic CpG sites across three cohorts, 
gene expression was not assessed in these samples. To 
address this, the sexually dimorphic placental methylome 
data were integrated with an existing genomic dataset in 
order to establish functional epigenetics. Future research 
should integrate data CpG methylation, as well as 
mRNA and protein expression. A potential confounder 
to these analyses is gestational age [43,44]. To address this, 
we integrated CpG methylation across three cohorts 
with varying gestational age, and found strong conserva-
tion. Last, future research should characterize X-inactive 
and X-active methylation patterns, through sequencing, 
to allow for male-female X-chromosome comparisons. 
These additional data would enhance the understanding 
of functional differences between methylation between 
males and females.
In conclusion, this study demonstrates sexual dimor-
phism at the level of the human placental DNA meth-
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Figure 4. Distribution of sex-dependent differential methylation by region for all probes. (A) displays probe 
locations for overall, hypermethylated and hypomethylated autosomal probes. (B) displays probe locations for 
overall, hypermethylated and hypomethylated X-chromosome probes.
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ylome. The epigenetic dimorphism observed could 
result in the sex-dependent transport of toxicants, 
nutrients and signaling molecules across the placenta, 
thereby resulting in a sex-dependent response of the 
fetus. Furthermore, it is possible that these differences 
could have consequences for both early and later-life 
health outcomes. The sexually dimorphic nature of the 
placental methylome may be a key factor to consider 
when examining sex-dependent outcomes in children 
following adverse exposures during the prenatal period.
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Executive summary
•	 The placenta provides an interface between the maternal and fetal compartments transporting nutrients, 
signaling molecules and toxic substances between mother and fetus.
•	 Differences in CpG methylation between male and female placentas may provide mechanistic understanding 
for sex-based differences observed, following adverse exposures during the prenatal period.
•	 To investigate sex-based differences in the epigenome of the placenta, we analyzed DNA methylation in 
relation to fetal sex using genome-wide techniques comparing data from three separate US-based cohorts.
•	 Methylation at 2745 probe (n = 587 genes) was identified and replicated, with enrichment of binding 
sites for transcription factors previously related to sexually dimorphic gene expression and environmental 
contaminants.
•	 Genes with sex-based differential methylation in the placenta enrich for functions related to response to 
environmental exposures including: cellular transport, immune response and growth/transcription factors.
•	 Within the placental DNA methylome, differences in the regulation of genes related to crucial biological 
functions may account for sex-specific effects of adverse in utero environments.
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